Recent News

• 04.07.2025 - David-Alexandre Gros, MD, on the Work to Bring Porcine Kidney Transplant to the Clinic
• 03.28.2025 - Gene Editing, Next-Gen Antibodies Key to Unlocking Animal-to-Human Transplants
• 03.20.2025 - Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
• 03.11.2025 - Leerink Partners Global Healthcare Conference
• 03.05.2025 - David-Alexandre Gros, MD, on Addressing Unmet Needs in End Stage Kidney Disease With Genetically Modified Porcine Kidney Transplant
• 03.04.2025 - Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
• 02.27.2025 - Scrip Asks… What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances
• 02.27.2025 - CD40L Blocker Tegoprubart Playing Key Role in Xenotransplantation
• 02.12.2025 - A Second Person Has Received a Pig Kidney Transplant
• 02.12.2025 - For Second Kidney Xenotransplant Patient Discharged, Immunosuppression Is Key

Recent Filings

• 03.20.2025 - EX-99.1 EX-99.1
• 03.20.2025 - 8-K Current report
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors